Ginkgo Bioworks Holdings Inc
NYSE:DNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
US |
|
Eniro Group AB
STO:ENRO
|
SE |
|
Iriso Electronics Co Ltd
TSE:6908
|
JP |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
UGI Corp
NYSE:UGI
|
US |
|
General Dynamics Corp
NYSE:GD
|
US |
|
Hitachi Ltd
F:HIAA
|
JP |
|
CIELO SA Instituicao de Pagamento
F:28MA
|
BR |
|
A
|
Alliance Pharma PLC
LSE:APH
|
UK |
|
N
|
Novozymes A/S
DUS:NZM2
|
DK |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
A
|
AG Mortgage Investment Trust Inc
NYSE:MITT
|
US |
Wall St Price Targets
DNA Price Targets Summary
Ginkgo Bioworks Holdings Inc
According to Wall Street analysts, the average 1-year price target for
DNA is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DNA's stock price target?
Price Target
10.2
USD
According to Wall Street analysts, the average 1-year price target for
DNA is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Ginkgo Bioworks Holdings Inc?
Projected CAGR
21%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 21%.